How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

A mysterious countdown briefly appeared on Taylor Swift's official website April 30 — and it was enough to send fans into full detective mode. The clock, which was live for roughly 10 minutes before ...

The World Cup is coming back to North America for the first time since 1994, which means the hype machine is officially warming up and there’s no turning it off now. Over the next few months, Yahoo ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Horizon head of portfolio management Zachary Hill says the news could increase anxiety in software trading on ‘The Claman Countdown.’ Laffer Tengler Investments CEO and CIO Nancy Tengler discusses the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...